Results 261 to 270 of about 2,312,760 (293)
Some of the next articles are maybe not open access.

Proteasome inhibition for antibody-mediated rejection

Current Opinion in Organ Transplantation, 2009
The purpose of this review is to describe the biochemistry and physiology of proteasome inhibition and to discuss recent studies with proteasome inhibitor therapy in organ transplantation.Traditional antihumoral therapies do not deplete plasma cells, the source of antibody production.
Jason J, Everly   +3 more
openaire   +2 more sources

Acute Rejection and Antibody-Mediated Rejection in Lung Transplantation

Clinics in Chest Medicine, 2017
Despite advances in immunosuppression over the past 25 years, acute cellular rejection remains a common complication early after lung transplantation. Although acute cellular rejection has often not resulted in clinical signs or symptoms of allograft dysfunction, it has been widely recognized as a strong independent risk factor for the development of ...
openaire   +2 more sources

Subclinical Antibody-Mediated Rejection

Transplantation, 2017
Manuel, Arias   +8 more
openaire   +2 more sources

[Antibody-mediated acute rejection].

Nephrologie & therapeutique, 2009
Antibody-mediated acute rejection is a frequent and severe complication of kidney transplantation. It has a poor prognosis and is often resistant to conventional treatment, which warrants treatment before transplantation to reduce the risk and after to improve the diagnosis, treatment, and follow-up.
C, Lefaucheur, D, Nochy, D, Glotz
openaire   +1 more source

Antibody-Mediated Rejection

Transplantation, 2014
Manuel, Arias   +16 more
openaire   +2 more sources

Antibody-Mediated Vascular Rejection of Kidney Allografts: A Population-Based Study

Lancet, The, 2013
Denis Glotz   +2 more
exaly  

Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants

American Journal of Transplantation, 2013
Philip F Halloran   +2 more
exaly  

Home - About - Disclaimer - Privacy